Yoh Terada

Title: Yoh Terada: Innovator in Pharmaceutical Compounds

Introduction

Yoh Terada is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target intestinal phosphate transporters. With a total of 6 patents to his name, Terada's work is focused on addressing medical conditions related to hyperphosphatemia.

Latest Patents

One of Terada's latest patents involves a tetrahydrobenzothiophene compound. The purpose of this compound is to provide an agent that has an intestinal phosphate transporter (NPT-IIb) inhibitory action, which is useful for treating and preventing hyperphosphatemia. The compound is designed to inhibit NPT-IIb, making it a valuable active ingredient in therapeutic applications. Another significant patent is for an aminoalkyl-substituted N-thienylbenzamide derivative. This compound also aims to inhibit the intestinal phosphate transporter (NPT-IIb) and serves as an active ingredient for treating and preventing hyperphosphatemia.

Career Highlights

Yoh Terada is currently associated with Astellas Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His research and development efforts have led to the creation of compounds that hold promise for improving patient outcomes in managing phosphate levels.

Collaborations

Terada has collaborated with notable colleagues such as Shunichiro Hachiya and Masanori Miura. Their combined expertise has contributed to the advancement of their research projects and the successful development of new pharmaceutical agents.

Conclusion

Yoh Terada's contributions to the field of pharmaceuticals, particularly in developing compounds for treating hyperphosphatemia, highlight his innovative spirit and dedication to improving healthcare. His work continues to pave the way for new therapeutic options in the medical community.